Trials / Completed
CompletedNCT04716647
Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research
A Community-Based Participatory Research to Assess the Feasibility of Ayurveda Intervention in Patients With Mild-to-Moderate COVID-19
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Aarogyam UK · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Innovative strategies are required to manage COVID-19 in the communities. Back to Roots community based project was a collaborative, pilot intervention program in British Asian community to assess the efficacy and safety of Ayurveda intervention in relieving symptoms of mild-to-moderate COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ayurveda | Dosage was used in common range (Ashwagandha: Doses range from 250 mg to 5 g; Giloy: range from 500mg to 1g; Tulsi: 500mg-1g) Dosage were altered based on age, weight and severity of symptoms. |
Timeline
- Start date
- 2020-10-09
- Primary completion
- 2020-12-12
- Completion
- 2020-12-18
- First posted
- 2021-01-20
- Last updated
- 2021-01-20
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04716647. Inclusion in this directory is not an endorsement.